Professor Amanj Kurdi

Strathclyde Institute of Pharmacy and Biomedical Sciences

Contact

Personal statement

Professor Kurdi is a Professor of Pharmacoepidemiology and Pharmacy Practice. He specialises in Pharmacoepidemiology and Drug Utilisation Research, especially concerning cardiovascular diseases, diabetes, and antibiotics. This includes studying medication adherence and persistence through the analysis of secondary databases and patient-level data, utilising a range of statistical and analytical methods.

Additionally, Professor Kurdi is keen on exploring Health Service Research and the evaluation of health policies and clinical guidelines' effects. Open to both national and international collaborations with fellow researchers and academics, Dr. Kurdi actively participates in events and conferences like EuroDURG and ICPE, fostering a collaborative environment for advancing research in these areas.

Back to staff profile

Publications

Study protocol for optimising antipsychotic prescribing among hospitalised patients in the acute care setting in Scotland : a national retrospective cohort study
Goswami Cosmika, Mueller Tanja, Wall Alexa, Johnson Chris F, Grosset David, Bennie Marion, Kurdi Amanj
BMJ Open Vol 15 (2025)
https://doi.org/10.1136/bmjopen-2025-098927
Prevalence and associated factors for purchasing of antibiotics without a prescription among patients in rural South Africa : implications for addressing antimicrobial resistance
Maluleke Tiyani, Maluleke Morgan Tiyiselani, Ramdas Nishana, Jelić Ana Golić, Kurdi Amanj, Chigome Audrey, Campbell Stephen M, Marković-Peković Vanda, Schellack Natalie, Godman Brian, Meyer Johanna
Antibiotics (2025)
Can increasing the number and role of community pharmacists in South Africa help address rising antimicrobial resistance rates, and what are the implications?
Maluleke Tiyani Milta, Schellack Natalie, Kalungia Aubrey Chichonyi, Rehman Inaam Ur, Moodley Rajatheran, Sefah Israel Abebrese, Jelić Ana Golić, Kurdi Amanj, Godman Brian, Meyer Johanna C
SA Pharmaceutical Journal Vol 92 (2025)
https://doi.org/10.36303/SAPJ.3898
Pregnancy, baby, and childhood outcomes from using anti-seizure medication during pregnancy
Moore Emily, Millar Morven, Merrick Rachel, Mueller Tanja, Stark Victoria, Jarvis Lynne, Kurdi Amanj, Hopkins Leanne, McTaggart Stuart, Vieira Rute, Bennie Marion, Wood Rachael
Communications Medicine (2025)
Impact of gabapentinoids’ reclassification policy and COVID-19 on gabapentinoids’ utilization pattern and their associated mortality in Scotland and Northern Ireland : a segmental regression analysis
Alrahmani Abdullah, Azeez Mabast, Baker Sahar, Kurdi Amanj
Expert Review of Clinical Pharmacology (2025)
https://doi.org/10.1080/17512433.2025.2587174
A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class
Madanat Faisal, Noorsaeed Solafa, Alkhlaifat Rahaf, Mueller Tanja, Kurdi Amanj
Expert Review of Clinical Pharmacology (2025)
https://doi.org/10.1080/17512433.2025.2585449

More publications

Back to staff profile

Professional Activities

Invited Guest Speaker at the 15th International Congress of Pharmaceutical Sciences (CIFARP 2025)around Real-world evidence
Speaker
29/10/2025
CPD course: Alkitab university pharmacy students summer school
Organiser
7/7/2025
NORDIC Social Pharmacy Conference 2025
Organiser
4/6/2025
External Examiner for the “Professional Certificate in Pharmacoepidemiology & Pharmacovigilance” course at London School of Hygiene and Tropical Medicine
Examiner
24/2/2025
Iraqi Journal of Pharmacy (Journal)
Peer reviewer
13/8/2024
Advances in Pharmacy and Pharmacoepidemiology Education in Kenya and Globally
Speaker
13/6/2024

More professional activities

Projects

Tackling antimicrobial resistance in Saudi Arabia: a multidisciplinary program to instigating evidence-based, theory-driven antimicrobial stewardship interventions using mixed-method approach
Elrggal, Mahmoud (CoPI) Kurdi, Amanj (Principal Investigator)
A 48 months project funded by The Saudi Basic Science Initiative, Research Development and Innovation Authority (RDIA), ~£300K
01-Jan-2025 - 30-Jan-2029
Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies
Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
01-Jan-2024 - 30-Jan-2025
Cancer Medicines Outcomes Programme - Public Health Scotland
Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
01-Jan-2024 - 31-Jan-2027
Prescribing medicines use in pregnancy: A scoping review protocol
Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
10-Jan-2024 - 14-Jan-2024
PHS Medicines Programme
Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)
01-Jan-2023 - 30-Jan-2028
Profiling and assessing medicines use in pregnancy in Scotland: a population-based, whole system prescribing approach using routine data from clinical care
Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Co-investigator)
01-Jan-2023 - 30-Jan-2027

More projects

Back to staff profile

Contact

Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences

Email: amanj.baker@strath.ac.uk
Tel: 548 2181